Cilostazol, a phosphodiesterase inhibitor, prevents no-reflow and hemorrhage in mice with focal cerebral ischemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cilostazol, a phosphodiesterase inhibitor, prevents no-reflow and hemorrhage in mice with focal cerebral ischemia

Published:2012-01 Issue:1 Volume:233 Page:523-533
ISSN:0014-4886
Container-title:Experimental Neurology
language:en
Short-container-title:Experimental Neurology

Author:

Hase Yoshiki,Okamoto Yoko,Fujita Youshi,Kitamura Akihiro,Nakabayashi Hitomi,Ito Hidefumi,Maki Takakuni,Washida Kazuo,Takahashi Ryosuke,Ihara Masafumi

Publisher

Elsevier BV

Subject

Developmental Neuroscience,Neurology

Reference33 articles.

1. Integrin alpha(IIb)beta(3) inhibitor preserves microvascular patency in experimental acute focal cerebral ischemia;Abumiya;Stroke,2000

2. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator;Alexandrov;Neurology,2002

3. Ischemic stunning of the brain: early recanalization without immediate clinical improvement in acute ischemic stroke;Alexandrov;Stroke,2004

4. Oxygen radicals in focal cerebral ischemia;Chan;Brain Pathol.,1994

5. Blocking pterygopalatine arterial blood flow decreases infarct volume variability in a mouse model of intraluminal suture middle cerebral artery occlusion;Chen;J. Neurosci. Methods,2008

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Incomplete Microcirculatory Reperfusion After Endovascular Thrombectomy: Focus on Inhibition of the Glycoprotein IIb/IIIa Receptor Pathway;Stroke: Vascular and Interventional Neurology;2024-03

2. No-reflow after recanalization in ischemic stroke: From pathomechanisms to therapeutic strategies;Journal of Cerebral Blood Flow & Metabolism;2024-02-29

3. No‐reflow after stroke reperfusion therapy: An emerging phenomenon to be explored;CNS Neuroscience & Therapeutics;2024-02

4. Emerging diagnostic markers and therapeutic targets in post-stroke hemorrhagic transformation and brain edema;Frontiers in Molecular Neuroscience;2023-12-21

5. Efficacy and Safety of Cilostazol in Mild Cognitive Impairment;JAMA Network Open;2023-12-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3